Compare ACON & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACON | OXBR |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Property-Casualty Insurers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.1M |
| IPO Year | 2022 | 2014 |
| Metric | ACON | OXBR |
|---|---|---|
| Price | $2.29 | $1.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.00 | $5.00 |
| AVG Volume (30 Days) | ★ 61.1K | 21.5K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | 37.78 |
| EPS | N/A | ★ 0.02 |
| Revenue | $75,730.00 | ★ $2,577,000.00 |
| Revenue This Year | $87.22 | $80.09 |
| Revenue Next Year | N/A | $85.22 |
| P/E Ratio | ★ N/A | $67.00 |
| Revenue Growth | 65.62 | ★ 371.98 |
| 52 Week Low | $1.95 | $0.66 |
| 52 Week High | $12.03 | $2.85 |
| Indicator | ACON | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 48.81 |
| Support Level | $1.95 | $1.21 |
| Resistance Level | $2.50 | $1.45 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 8.62 | 35.12 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.